Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Matricaria chamomilla 1% mouth rinse is an investigational herbal preparation developed by the Institute of Dental Sciences in Bareilly, India, for the treatment of chronic periodontitis. Formulated as an adjunctive therapy to scaling and root planing (SRP), this mouth rinse utilizes the anti-inflammatory and antimicrobial properties of chamomile extract to reduce plaque formation, gingival inflammation, and bacterial colonization within periodontal pockets. The preparation was developed with pharmaceutical assistance from MJP Rohilkhand University. In clinical studies, it has been evaluated against chlorhexidine and placebo to assess its efficacy in improving clinical parameters such as plaque index, gingival index, and probing pocket depth over a three-month period.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Matricaria chamomilla 1% mouth rinse.